Correlation Between Par Drugs and AXISILVER

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Par Drugs and AXISILVER at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Par Drugs and AXISILVER into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Par Drugs And and AXISILVER, you can compare the effects of market volatilities on Par Drugs and AXISILVER and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Par Drugs with a short position of AXISILVER. Check out your portfolio center. Please also check ongoing floating volatility patterns of Par Drugs and AXISILVER.

Diversification Opportunities for Par Drugs and AXISILVER

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Par and AXISILVER is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Par Drugs And and AXISILVER in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AXISILVER and Par Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Par Drugs And are associated (or correlated) with AXISILVER. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AXISILVER has no effect on the direction of Par Drugs i.e., Par Drugs and AXISILVER go up and down completely randomly.

Pair Corralation between Par Drugs and AXISILVER

Assuming the 90 days trading horizon Par Drugs is expected to generate 1.5 times less return on investment than AXISILVER. In addition to that, Par Drugs is 1.46 times more volatile than AXISILVER. It trades about 0.09 of its total potential returns per unit of risk. AXISILVER is currently generating about 0.2 per unit of volatility. If you would invest  9,831  in AXISILVER on April 24, 2025 and sell it today you would earn a total of  1,633  from holding AXISILVER or generate 16.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Par Drugs And  vs.  AXISILVER

 Performance 
       Timeline  
Par Drugs And 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Par Drugs And are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Par Drugs may actually be approaching a critical reversion point that can send shares even higher in August 2025.
AXISILVER 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AXISILVER are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, AXISILVER showed solid returns over the last few months and may actually be approaching a breakup point.

Par Drugs and AXISILVER Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Par Drugs and AXISILVER

The main advantage of trading using opposite Par Drugs and AXISILVER positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Par Drugs position performs unexpectedly, AXISILVER can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AXISILVER will offset losses from the drop in AXISILVER's long position.
The idea behind Par Drugs And and AXISILVER pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA